These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

767 related items for PubMed ID: 29242064

  • 1. Hypoxia-inducible factor 1 in clinical and experimental aortic aneurysm disease.
    Wang W, Xu B, Xuan H, Ge Y, Wang Y, Wang L, Huang J, Fu W, Michie SA, Dalman RL.
    J Vasc Surg; 2018 Nov; 68(5):1538-1550.e2. PubMed ID: 29242064
    [Abstract] [Full Text] [Related]

  • 2. Treatment with the Prolyl Hydroxylase Inhibitor JNJ Promotes Abdominal Aortic Aneurysm Progression in Diabetic Mice.
    Guo J, Shoji T, Ge Y, Zheng X, Li Y, Zhao S, Ikezoe T, Liu S, Huang J, Wang W, Xu B, Dalman RL.
    Eur J Vasc Endovasc Surg; 2022 Mar; 63(3):484-494. PubMed ID: 34872812
    [Abstract] [Full Text] [Related]

  • 3. Inhibition of miR-188-5p Suppresses Progression of Experimental Abdominal Aortic Aneurysms.
    Huang T, Liu S, Liu R, Pan B, Wang W.
    J Cardiovasc Pharmacol; 2021 Jan 01; 77(1):107-114. PubMed ID: 33105327
    [Abstract] [Full Text] [Related]

  • 4. Inhibition or deletion of angiotensin II type 1 receptor suppresses elastase-induced experimental abdominal aortic aneurysms.
    Xuan H, Xu B, Wang W, Tanaka H, Fujimura N, Miyata M, Michie SA, Dalman RL.
    J Vasc Surg; 2018 Feb 01; 67(2):573-584.e2. PubMed ID: 28434702
    [Abstract] [Full Text] [Related]

  • 5. Peptide inhibitor of CXCL4-CCL5 heterodimer formation, MKEY, inhibits experimental aortic aneurysm initiation and progression.
    Iida Y, Xu B, Xuan H, Glover KJ, Tanaka H, Hu X, Fujimura N, Wang W, Schultz JR, Turner CR, Dalman RL.
    Arterioscler Thromb Vasc Biol; 2013 Apr 01; 33(4):718-26. PubMed ID: 23288157
    [Abstract] [Full Text] [Related]

  • 6. Spermidine Suppresses Development of Experimental Abdominal Aortic Aneurysms.
    Liu S, Huang T, Liu R, Cai H, Pan B, Liao M, Yang P, Wang L, Huang J, Ge Y, Xu B, Wang W.
    J Am Heart Assoc; 2020 Apr 21; 9(8):e014757. PubMed ID: 32308093
    [Abstract] [Full Text] [Related]

  • 7. Hyperglycemia limits experimental aortic aneurysm progression.
    Miyama N, Dua MM, Yeung JJ, Schultz GM, Asagami T, Sho E, Sho M, Dalman RL.
    J Vasc Surg; 2010 Oct 21; 52(4):975-83. PubMed ID: 20678880
    [Abstract] [Full Text] [Related]

  • 8. Hypoxia-Inducible Factor-1α in Smooth Muscle Cells Protects Against Aortic Aneurysms-Brief Report.
    Imanishi M, Chiba Y, Tomita N, Matsunaga S, Nakagawa T, Ueno M, Yamamoto K, Tamaki T, Tomita S.
    Arterioscler Thromb Vasc Biol; 2016 Nov 21; 36(11):2158-2162. PubMed ID: 27562915
    [Abstract] [Full Text] [Related]

  • 9. Deletion of hypoxia-inducible factor-1α in myeloid lineage exaggerates angiotensin II-induced formation of abdominal aortic aneurysm.
    Takahara Y, Tokunou T, Kojima H, Hirooka Y, Ichiki T.
    Clin Sci (Lond); 2017 Apr 01; 131(7):609-620. PubMed ID: 28196857
    [Abstract] [Full Text] [Related]

  • 10. Suppression of abdominal aortic aneurysm formation by inhibition of prolyl hydroxylase domain protein through attenuation of inflammation and extracellular matrix disruption.
    Watanabe A, Ichiki T, Sankoda C, Takahara Y, Ikeda J, Inoue E, Tokunou T, Kitamoto S, Sunagawa K.
    Clin Sci (Lond); 2014 May 01; 126(9):671-8. PubMed ID: 24256203
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of hypoxia inducible factor-1α attenuates abdominal aortic aneurysm progression through the down-regulation of matrix metalloproteinases.
    Tsai SH, Huang PH, Hsu YJ, Peng YJ, Lee CH, Wang JC, Chen JW, Lin SJ.
    Sci Rep; 2016 Jul 01; 6():28612. PubMed ID: 27363580
    [Abstract] [Full Text] [Related]

  • 12. Analysis of in situ and ex vivo vascular endothelial growth factor receptor expression during experimental aortic aneurysm progression.
    Tedesco MM, Terashima M, Blankenberg FG, Levashova Z, Spin JM, Backer MV, Backer JM, Sho M, Sho E, McConnell MV, Dalman RL.
    Arterioscler Thromb Vasc Biol; 2009 Oct 01; 29(10):1452-7. PubMed ID: 19574559
    [Abstract] [Full Text] [Related]

  • 13. H19 Induces Abdominal Aortic Aneurysm Development and Progression.
    Li DY, Busch A, Jin H, Chernogubova E, Pelisek J, Karlsson J, Sennblad B, Liu S, Lao S, Hofmann P, Bäcklund A, Eken SM, Roy J, Eriksson P, Dacken B, Ramanujam D, Dueck A, Engelhardt S, Boon RA, Eckstein HH, Spin JM, Tsao PS, Maegdefessel L.
    Circulation; 2018 Oct 09; 138(15):1551-1568. PubMed ID: 29669788
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of VEGF (Vascular Endothelial Growth Factor)-A or its Receptor Activity Suppresses Experimental Aneurysm Progression in the Aortic Elastase Infusion Model.
    Xu B, Iida Y, Glover KJ, Ge Y, Wang Y, Xuan H, Hu X, Tanaka H, Wang W, Fujimura N, Miyata M, Shoji T, Guo J, Zheng X, Gerritsen M, Kuo C, Michie SA, Dalman RL.
    Arterioscler Thromb Vasc Biol; 2019 Aug 09; 39(8):1652-1666. PubMed ID: 31294623
    [Abstract] [Full Text] [Related]

  • 15. Quercetin Downregulates Cyclooxygenase-2 Expression and HIF-1α/VEGF Signaling-Related Angiogenesis in a Mouse Model of Abdominal Aortic Aneurysm.
    Wang L, Wu H, Xiong L, Liu X, Yang N, Luo L, Qin T, Zhu X, Shen Z, Jing H, Chen J.
    Biomed Res Int; 2020 Aug 09; 2020():9485398. PubMed ID: 32908926
    [Abstract] [Full Text] [Related]

  • 16. CD95-ligand contributes to abdominal aortic aneurysm progression by modulating inflammation.
    Liu Z, Fitzgerald M, Meisinger T, Batra R, Suh M, Greene H, Penrice AJ, Sun L, Baxter BT, Xiong W.
    Cardiovasc Res; 2019 Mar 15; 115(4):807-818. PubMed ID: 30428004
    [Abstract] [Full Text] [Related]

  • 17. No Effect of Hypercholesterolemia on Elastase-Induced Experimental Abdominal Aortic Aneurysm Progression.
    Ikezoe T, Shoji T, Guo J, Shen F, Lu HS, Daugherty A, Nunokawa M, Kubota H, Miyata M, Xu B, Dalman RL.
    Biomolecules; 2021 Sep 30; 11(10):. PubMed ID: 34680067
    [Abstract] [Full Text] [Related]

  • 18. Paeonol Ameliorates Abdominal Aortic Aneurysm Progression by the NF-κB Pathway.
    Chen S, Luo K, Bian S, Chen J, Qiu R, Wu X, Li G.
    Ann Vasc Surg; 2021 Nov 30; 77():255-262. PubMed ID: 34411666
    [Abstract] [Full Text] [Related]

  • 19. Treatment With Small Molecule Inhibitors of Advanced Glycation End-Products Formation and Advanced Glycation End-Products-Mediated Collagen Cross-Linking Promotes Experimental Aortic Aneurysm Progression in Diabetic Mice.
    Li Y, Zheng X, Guo J, Samura M, Ge Y, Zhao S, Li G, Chen X, Shoji T, Ikezoe T, Miyata M, Xu B, Dalman RL.
    J Am Heart Assoc; 2023 May 16; 12(10):e028081. PubMed ID: 37158066
    [Abstract] [Full Text] [Related]

  • 20. Role of vascular endothelial growth factor-A in development of abdominal aortic aneurysm.
    Kaneko H, Anzai T, Takahashi T, Kohno T, Shimoda M, Sasaki A, Shimizu H, Nagai T, Maekawa Y, Yoshimura K, Aoki H, Yoshikawa T, Okada Y, Yozu R, Ogawa S, Fukuda K.
    Cardiovasc Res; 2011 Jul 15; 91(2):358-67. PubMed ID: 21436157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.